TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming.

TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming.
复制标题

DOI:
10.1038/s41590-021-00903-7
复制
发表时间:
2021-04
期刊:
影响因子:
30.5
通讯作者:
Blander JM
Blander JM
中科院分区:
医学1区
文献类型:
--
作者:
Barbet G;Nair-Gupta P;Schotsaert M;Yeung ST;Moretti J;Seyffer F;Metreveli G;Gardner T;Choi A;Tortorella D;Tampé R;Khanna KM;García-Sastre A;Blander JM

文献摘要

参考文献

被引文献

相似文献

经典的MHC-I递呈依赖于与抗原处理(TAP)相关的转运蛋白(TAP)将胞浆多肽运送到内质网(ER)。病毒禁用TAP来阻止MHC-I呈现,并逃避细胞毒性CD8+T细胞。针对这些病毒启动CD8+T细胞被认为完全依赖于未感染的TAP功能树突状细胞(DC)的交叉呈递。我们发现,即使在所有造血细胞中没有TAP的情况下,也可以在病毒感染期间动员保护性CD8+T细胞。阻断TAP可耗尽MHC-I的内体循环室(ERC),从而损害Toll样受体调节的交叉呈现。相反,MHC-I聚集在内质网高尔基体中间隔室(ERGIC),远离Toll样受体的控制,并利用ER-SNARE Sec22b介导的囊泡交通与内化抗原相交,拯救交叉递呈。因此,当DC中经典的MHC-I递呈和ERC依赖的交叉递呈受损时,依赖于ERGIC来源的MHC-I计数器的细胞自主非经典性交叉递呈利用功能障碍来调节CD8+T细胞的启动。
Classic MHC-I presentation relies on shuttling cytosolic peptides into the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP). Viruses disable TAP to block MHC-I presentation and evade cytotoxic CD8+ T cells. Priming CD8+ T cells against these viruses is thought to rely solely on cross-presentation by uninfected TAP-functional dendritic cells (DCs). We found that protective CD8+ T cells could be mobilized during viral infection even when TAP was absent in all hematopoietic cells. TAP blockade depleted the endosomal recycling compartment (ERC) of MHC-I and as such impaired Toll-like receptor-regulated cross-presentation. Instead, MHC-I accumulated in ER-Golgi intermediate compartments (ERGIC), sequestered away from Toll-like receptor control, and coopted ER-SNARE Sec22b-mediated vesicular traffic to intersect with internalized antigen and rescue cross-presentation. Thus, when classic MHC-I presentation and ERC-dependent cross-presentation are impaired in DCs, cell-autonomous non-canonical cross-presentation relying on ERGIC-derived MHC-I counters TAP dysfunction to nevertheless mediate CD8+ T cell priming.
DOI: 10.1084/jem.20170229
发表时间: 2017-08-07
期刊: The Journal of experimental medicine
影响因子: --
作者:
Alloatti A;Rookhuizen DC;Joannas L;Carpier JM;Iborra S;Magalhaes JG;Yatim N;Kozik P;Sancho D;Albert ML;Amigorena S
通讯作者: Amigorena S
DOI: 10.1172/jci60659
发表时间: 2012-11-01
影响因子: 15.9
作者:
Helft, Julie;Manicassamy, Balaji;Merad, Miriam
通讯作者: Merad, Miriam
DOI: 10.4049/jimmunol.1501925
发表时间: 2016-11-01
影响因子: 4.4
作者:
Lawand, Myriam;Abramova, Anastasia;van Endert, Peter
通讯作者: van Endert, Peter
DOI: 10.1155/2014/472978
发表时间: 2014
影响因子: --
作者:
Halenius A;Hengel H
通讯作者: Hengel H
DOI: 10.1146/annurev-immunol-032712-095910
发表时间: 2013
影响因子: 29.7
作者:
Blum JS;Wearsch PA;Cresswell P
通讯作者: Cresswell P